PNPLA3 and steatosis: Although we did not exclude steatosis by imaging in all control subjects, the metabolic and clinical selection criteria used have a high specificity to exclude this condition in the general population [30], and the different distribution of PNPLA3 genotype between patients and healthy subjects with very low probability of steatosis indirectly confirmed the accurate selection of controls [16,17].